Home › NDC Lookup › RxCUI directory › RxCUI 1810484

0.4 ML granisetron 25 MG/ML Prefilled Syringe — RxCUI 1810484

Name: 0.4 ML granisetron 25 MG/ML Prefilled Syringe (RxCUI 1810484)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1810484 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1810484

Official name0.4 ML granisetron 25 MG/ML Prefilled Syringe

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asgranisetron 10 MG per 0.4 ML Prefilled Syringe; granisetron 10 MG in 0.4 ML Prefilled Syringe

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)1,285 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Granisetron: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Granisetron is an anti-nausea medicine. It's mainly used to prevent nausea and vomiting that cancer chemotherapy or radiation therapy can cause. Depending on which product you've b...
The Sancuso patch delivers granisetron slowly through your skin over up to 7 days — you apply it to your upper outer arm at least 24 hours before chemotherapy starts and leave it o...
How does the Sancuso patch work differently from the pill or injection?
The most common ones are headache and constipation — these are the side effects most often reported in clinical studies. Some people also notice fever, stomach pain, or a slight ch...

📖 Read our full Granisetron guide →

🕸️ Concept Web — How 0.4 ML granisetron 25 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.4 ML granisetron 25 MG/ML Prefilled Syringe RxCUI 1810484 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Granisetron 26237 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Sustol 1810485 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Granisetron Prefilled Syringe 1810483 SCDF
- Granisetron Injectable Product 1156890 SCDG
- Granisetron Prefilled Syringe [Sustol] 1810487 SBDF
- Sustol Injectable Product 1810488 SBDG
- Prefilled Syringe 721656 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Granisetron 25 MG/ML 1810482 SCDC
- 0.4 ML granisetron 25 MG/ML Prefilled Syringe [Sustol] 1810489 SBD
- Granisetron 25 MG/ML [Sustol] 1810486 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Granisetron 25 MG/ML SCDC · 1810482
Granisetron Prefilled Syringe SCDF · 1810483
Granisetron Injectable Product SCDG · 1156890

Brand-Name Concepts

0.4 ML granisetron 25 MG/ML Prefilled Syringe [Sustol] SBD · 1810489
Granisetron 25 MG/ML [Sustol] SBDC · 1810486
Granisetron Prefilled Syringe [Sustol] SBDF · 1810487
Sustol Injectable Product SBDG · 1810488
Sustol BN · 1810485

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1810484 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
47426-0101-06	6 KIT in 1 CARTON (47426-101-06) / 1 SYRINGE, GLASS in 1 KI...	SUSTOL	Heron Therapeutics, Inc.	2016-08-09

Observed labelers: Heron Therapeutics, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1627	Inj, granisetron, xr, 0.1 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.